CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation

Slides:

Advertisements

Similar presentations

Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. Benefit of Anticoagulation Unlikely in Patients With Atrial.

Advertisements

Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Use and Outcomes of Triple Therapy Among Older Patients.

Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: Data from the Mode Selection Trial (MOST) Kirsten E. Fleischmann,

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Diabetes: A Meta-Analysis Stavros Stavrakis, MD The American Journal.

Kiran Sidhu, MD, FRCPC, Anthony Tang, MD, FRCPC

New-onset Atrial Fibrillation Predicts Heart Failure Progression

Frontiers of anticoagulation therapy for atrial fibrillation

Should paroxysmal atrial fibrillation be treated during cardiac surgery? Patrick M. McCarthy, MD, Adarsh Manjunath, BA, Jane Kruse, RN, BSN, Adin-Cristian.

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Alfred A. Bartolucci, PhD, Michal Tendera, MD, George Howard, DrPH

Volume 13, Issue 6, Pages (June 2016)

Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal Gregory.

Role of the CHADS2 Score in Acute Coronary Syndromes

Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B

CHADS2 Score Predicts Postoperative Atrial Fibrillation in Patients Undergoing Elective Pulmonary Lobectomy Svetlana Kotova, MD, Mansen Wang, PhD, Katie.

Longitudinal Outcome of Isolated Mitral Repair in Older Patients: Results From 14,604 Procedures Performed From 1991 to 2007 Vinay Badhwar, MD, Eric.

Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Implementation Ratika Parkash, MD, MSc, François Philippon,

2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Laurent Macle, MD, John Cairns, MD, Kori.

Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control

Mechanisms, Clinical Significance, and Prevention of Cognitive Impairment in Patients With Atrial Fibrillation Lena Rivard, MD, MSc, Paul Khairy, MD,

Masaya Koshizaka, MD, PhD, Renato D. Lopes, MD, PhD, MHS, L

James H. O’Keefe, MD, Salman K. Bhatti, MD, Ata Bajwa, MD, James J

Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

Long-Term Risk of Ischemic Stroke After the Cox-Maze III Procedure for Atrial Fibrillation Anders Albåge, MD, PhD, Ulrik Sartipy, MD, PhD, Göran Kennebäck,

Volume 13, Issue 1, Pages (January 2016)

Dysfunctional Uterine Activity in Labour and Premature Adverse Cardiac Events: Population-Based Cohort Study Alyssa Kahane, BSc, Alison L. Park, MSc,

Cardiovascular Disease and CKD: Core Curriculum 2010

Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes Thomas Mueller,

Gregory Y.H. Lip, MD, Jonathan L. Halperin, MD, Hung-Fat Tse, MD, PhD

Sean M. Bagshaw, MD, MS, P. Diane Galbraith, BN, MS, L

Mild-to-moderate functional tricuspid regurgitation in patients undergoing mitral valve surgery Sun Kyun Ro, MD, Joon Bum Kim, MD, Sung Ho Jung, MD,

Self-Management of Anticoagulant Therapy in Mechanical Heart Valve Patients: A Matched Cohort Study Thomas Decker Christensen, MD, PhD, Flemming Skjøth,

Rate-control versus Rhythm-control Strategies and Outcomes in Septuagenarians with Atrial Fibrillation Nasir Shariff, MD, Ravi V. Desai, MD, Kanan Patel,

The Extent of Left Atrial Low-Voltage Areas Included in Pulmonary Vein Isolation Is Associated With Freedom from Recurrent Atrial Arrhythmia Dong Huang,

CHADS2 Score, Statin Therapy, and Risks of Atrial Fibrillation

Shikhar Agarwal, MD, MPH, Aatish Garg, MD, Akhil Parashar, MD, Lars G

Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk? Peter J. Zimetbaum, MD, Amit Thosani, MD, Hsing-Ting Yu, MPH, Yan.

2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Atul Verma, MD, John A. Cairns, MD, L.

Left atrial appendage exclusion: An alternative to anticoagulation in nonvalvular atrial fibrillation Kareem Bedeir, MBChB, MS, David R. Holmes, MD,

Isla M. Ogilvie, PhD, Nick Newton, PhD, Sharon A

Molly E. Waring, PhD, Jane S

Blood Pressure and Outcomes in Very Old Hypertensive Coronary Artery Disease Patients: An INVEST Substudy Scott J. Denardo, MD, Yan Gong, PhD, Wilmer.

Todd R. Vogel, MD, MPH, Viktor Y. Dombrovskiy, MD, PhD, MPH, Paul B

Should paroxysmal atrial fibrillation be treated during cardiac surgery? Patrick M. McCarthy, MD, Adarsh Manjunath, BA, Jane Kruse, RN, BSN, Adin-Cristian.

Optimizing Atrial Fibrillation Management

Volume 14, Issue 12, Pages (December 2017)

2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Jason G. Andrade, MD, Atul Verma, MD,

John R. Petrie, MD, PhD, Tomasz J. Guzik, MD, PhD, Rhian M

Recent Temporal Changes in Atherosclerotic Cardiovascular Diseases in Ontario: Clinical and Health Systems Impact Jack V. Tu, MD, PhD, Anam M. Khan,

Attainment of low-density lipoprotein cholesterol goal after endovascular treatment is associated with reduced cardiovascular events in patients with.

Valve replacement surgery for older individuals with preoperative atrial fibrillation: The effect of prosthetic valve choice and surgical ablation Ho.

Outcomes of infrainguinal bypass determined by age in the Vascular Study Group of New England Meghan Dermody, MD, MS, Christopher Homsy, MD, Yuanyuan.

Clinical utility of CHADS2 and CHA2DS2-VASc scoring systems for predicting postoperative atrial fibrillation after cardiac surgery Su-Kiat Chua, MD,

Dual antiplatelet therapy (clopidogrel and aspirin) is associated with increased all-cause mortality after carotid revascularization for asymptomatic.

Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney.

Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study Walid Saliba, MD, MPH, Naomi.

Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter

Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey Maura Marcucci, MD, Gregory Y.H. Lip,

Volume 8, Issue 3, Pages (March 2011)

Volume 10, Issue 9, Pages (September 2013)

International Journal of Cardiology

Strategies for Optimizing Glycemic Control and Cardiovascular Prognosis in Patients With Type 2 Diabetes Mellitus James H. O'Keefe, MD, Mohammad Abuannadi,

Erratum Canadian Journal of Cardiology

Figure 8. Stroke prevention strategy in patients with AF

Figure 1. Decision-making process of stroke prevention in patients with AF from Asia. The decision-making process includes stroke risk evaluation, OAC.

Targeted Therapeutic Drug Monitoring for Direct Oral Anticoagulants: What Is Its Potential Place and Can It Limit Black Swan Events? D. George Wyse,

Francisco Alcocer, MD, Marjan Mujib, MD, Bruce Lowman, MD, Mark A

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

The CHA(2)DS2-(VASc) stroke risk and HAS-BLED bleeding risk index are calculated by totalling the scores for each risk factor present.68–71 The lower graph.

Presentation transcript:

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation Taya V. Glotzer, MD, Anne S. Hellkamp, MS, Kerry L. Lee, PhD, Gervasio A. Lamas, MD Canadian Journal of Cardiology Volume 31, Issue 8, Pages 1004-1011 (August 2015) DOI: 10.1016/j.cjca.2015.02.020 Copyright © 2015 Canadian Cardiovascular Society Terms and Conditions

Figure 1 Association of CHA2DS2-VASc score with outcomes overall and by AF history. Forest plot of hazard ratios for each 1-point increase in score. AF, atrial fibrillation; CHA2DS2-VASc, Congestive HF, Hypertension, Age (≥ 75 years), Diabetes, Stroke/Transient Ischemic Attack, Vascular Disease, Age (65-74 years), Sex (Female); CI, confidence interval; HF, heart failure; HR, hazard ratio. Canadian Journal of Cardiology 2015 31, 1004-1011DOI: (10.1016/j.cjca.2015.02.020) Copyright © 2015 Canadian Cardiovascular Society Terms and Conditions

Figure 2 Association of CHADS2 score with outcomes overall and by AF history. Forest plot of hazard ratios for each 1-point increase in score. AF, atrial fibrillation; CHADS2, Congestive Heart Failure, Hypertension, Age (≥ 75 years), Diabetes, Stroke/Transient Ischemic Attack; CI, confidence interval; HF, heart failure; HR, hazard ratio. Canadian Journal of Cardiology 2015 31, 1004-1011DOI: (10.1016/j.cjca.2015.02.020) Copyright © 2015 Canadian Cardiovascular Society Terms and Conditions

Figure 3 (A) Kaplan-Meier plot of death or stroke by CHA2DS2-VASc score. (B) Kaplan-Meier plot of death or stroke by CHADS2 score. CHADS2, Congestive Heart Failure, Hypertension, Age (≥ 75), Diabetes, Stroke/Transient Ischemic Attack; CHA2DS2-VASc, Congestive HF, Hypertension, Age (≥ 75 years), Diabetes, Stroke/Transient Ischemic Attack, Vascular Disease, Age (65-74 years), Sex (Female). Canadian Journal of Cardiology 2015 31, 1004-1011DOI: (10.1016/j.cjca.2015.02.020) Copyright © 2015 Canadian Cardiovascular Society Terms and Conditions